Never said I did. However, longs have lost a nice chunk of change on their position from March 29's $29+ to today.
LIVE-AIR has two important limitations. First, while it demonstrated an improvement in survival in subjects with CRP<150 mg/L and aged <85, the study was not powered to observe a survival benefit, and indeed did not achieve statistical significance on this key secondary endpoint in the mITT population.
Second, the observations pertaining to benefits in the population that had CRP<150 mg/L and age <85 were exploratory.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.